- Available:In stock725
- Availability date:2020-07-30
- Dosage form:Tablets
- In stock:725 Items
the plant components that make up the bronchipret TP have secretolytic and antispasmodic properties.
Saponins from the roots of the primrose exhibit a secretolytic effect, which is achieved mainly using the reflex mechanism due to irritation of the sensitive nerve endings of the vagus nerve of the digestive tract.
Essential oils and flavonoids of thyme herb have a bronchospasmolytic and secretolytic effect. The antibacterial effect of the drug, due to the thymol component of the essential oil from thyme herb, was also confirmed.
Pharmacokinetics The thymol component of thyme essential oil is secreted mainly by the lungs. Flavonoids (e.g. apigenin, luteolin) thyme herbs are broken down by intestinal microflora and are well absorbed into the blood and excreted either unchanged or in the form of metabolites, mainly by the kidneys.
Treatment of acute and inflammatory diseases of the respiratory tract, accompanied by cough with the formation of viscous sputum.
Adults and children over the age of 12 take 1 tablet 3 times a day.
Tablets should be taken without chewing, washed down with a sufficient amount of liquid (mainly a glass of water), before meals.
The duration of treatment depends on the course of the disease. Usually the course of treatment is 1 week. If long-term treatment is necessary, the patient should consult a doctor. See also the information under SPECIAL INSTRUCTIONS and SIDE EFFECTS.
Increased individual sensitivity to the components of the drug, as well as other types of primroses or other medicinal plants of the family Labiaceae, to birch, wormwood and celery.
Gastrointestinal disturbances, including cramping, nausea, vomiting, diarrhea, rarely occur. hypersensitivity reactions are very rare, including difficulty breathing, skin rashes, itching, hives, swelling of the face, mouth and / or pharynx.
If any adverse reactions occur, discontinue use of the drug and consult a doctor.
If an allergic reaction occurs, tablets Bronchipret TP can not be used again.
Due to the content of glucose and lactose, the drug should not be taken in patients with hereditary galactose intolerance, lactase deficiency or malabsorption of glucose-galactose.
If symptoms persist for more than 1 week or difficulty breathing, fever, purulent or bloody sputum, the patient should consult a doctor immediately.
Patients with gastritis or a stomach ulcer should not use Bronchipret TP coated tablets without consulting a doctor.
Note for patients with diabetes. 1 tablet contains an average of 0.02 XE. The tablets are gluten free.
Use during pregnancy and lactation
Pregnancy. Due to insufficient data on the use of the drug should not be used during pregnancy and lactation.
Fertility. There is no data on the effect of the drug on the female ability to reproduce offspring. In experimental studies, no effect on fertility was observed.
Children. Due to the lack of safety studies, the drug should not be used in children under the age of 12 years.
The ability to influence the reaction rate when driving vehicles or working with other mechanisms. Does not affect.
Not marked. may be used in combination with antibacterial drugs.
Gastric upsets, vomiting, and diarrhea are possible. symptomatic treatment.
In the original packaging at a temperature not exceeding 25 ° c.